Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
0001193125-19-103996.pdf 0001193125-19-103996.rtf 0001193125-19-103996.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-102820.pdf 0001193125-19-102820.rtf 0001193125-19-102820.xls View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
0001193125-19-102877.pdf 0001193125-19-102877.rtf 0001193125-19-102877.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-009828.pdf 0000899243-19-009828.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-008813.pdf 0000899243-19-008813.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-008814.pdf 0000899243-19-008814.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0000899243-19-008815.pdf 0000899243-19-008815.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-074813.pdf 0001193125-19-074813.rtf 0001193125-19-074813.xls View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K
Annual Filings
0001193125-19-074893.pdf 0001193125-19-074893.rtf 0001193125-19-074893.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-065726.pdf 0001193125-19-065726.rtf 0001193125-19-065726.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon